Latest Publishing News

Page 4 of 64
Ocean Sciences has committed A$100,000 to a 12-month research program testing whether Sargassum-derived alginate can recover gold, silver and potentially rare earth elements from retired data centre hardware. The project gives the seaweed company a new industrial angle, but remains firmly at the laboratory stage.
Victor Sage
Victor Sage
28 Oct 2026
Perpetual Resources has expanded its Nevada Scheelite tungsten project more than 15-fold and reported selective underground samples grading up to 12.03% WO₃. The exploration momentum comes with a sharper funding question, with A$1.639 million in cash and an estimated 2.37 quarters of funding at 30 September.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Transurban has clarified that the I-24 Southeast Choice Lanes award involves US$21 billion in present-value payments to Tennessee, rather than the previously published US$24.8 billion headline figure. The concession also includes revenue-sharing provisions that could increase the state’s take if toll revenues or returns exceed agreed thresholds.
Victor Sage
Victor Sage
28 Oct 2026
Fortuna Metals has completed deeper drilling beneath its large inferred Mkanda rutile-graphite resource, returning broad mineralised intersections and a peak rutile grade of 3.43%. The company ended September with A$11.43 million in cash as it moves towards further resource definition and technical studies.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Neurotech International has dosed the first patient in its pivotal Phase 3 trial of NTI164, with all six Australian sites now active and up to 200 children planned for enrolment. The milestone sits alongside FDA clearance and fresh funding, but quarter-end cash covered only 1.24 quarters of historical operating outflows.
Ada Torres
Ada Torres
28 Oct 2026
The Takeovers Panel has ordered the forced sale of a substantial parcel of DGR Global shares after finding undisclosed associations and takeover-law breaches pushed related parties’ voting power as high as 45.43%. The orders also open the way for a takeover bid or scheme while imposing new controls on DGR’s board and major shareholders.
Victor Sage
Victor Sage
27 Oct 2026
Azzuro Resources has outlined conceptual exploration targets of up to 55 million tonnes across two Mongolian copper projects, while a strategic investment from Kerry Resources Logistics provides fresh funding for the next phase. The quarter also delivered high-grade Red Hill drilling, but the targets remain short of Mineral Resource status and quarter-end cash was only A$1.615 million.
Maxwell Dee
Maxwell Dee
27 Oct 2026
PhosCo has expanded its Tunisian phosphate exploration story with new mineralisation, premium-grade concentrate results and a proposed A$1.4 million investment from engineering group STUDI International. The next test is whether the imminent scoping study can convert those technical gains into a credible development case.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Bounty Oil & Gas is pursuing a 2,322 km² deepwater block offshore Liberia, but the asset remains unlicensed and requires parliamentary approval before a production sharing contract can be executed. The proposed acquisition brings major exploration potential alongside substantial dilution, contingent payments and a fresh $3.5 million capital raise.
Victor Sage
Victor Sage
27 Oct 2026
Alurion Resources has moved its Amargosa bauxite project into a field development program after completing its A$50 million IPO and ASX listing. Drilling, bulk sampling and logistics work are now feeding a direct-shipping-bauxite pre-feasibility study targeted for mid-2027.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Vintage Energy’s independently assessed 2P reserves have fallen to 12.4 PJe from 72.9 PJe, largely because Cooper Basin volumes were reclassified as contingent resources. The company says gas in place at Odin and Vali is effectively unchanged, but larger-scale development now depends on capital commitments and drilling results.
Victor Sage
Victor Sage
26 Oct 2026
Island Pharmaceuticals has secured approvals to use Galidesivir in Uganda’s Bundibugyo Ebola outbreak while advancing two complementary Marburg studies and expanding manufacturing. The progress comes with a sharper funding question: cash fell to A$7.83 million after quarterly operating outflows of A$4.93 million, leaving an estimated 1.6 quarters of funding.
Victor Sage
Victor Sage
26 Oct 2026

Browse the archive

Full archive